Roche Pharma AG (Germany) (DE)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
186
Publications
3702
Citations
171217
i10-index
1819
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Alzheimer's disease | 2006 | 3016 |
CSF and blood biomarkers for the diagnosis of Alzh... | 2016 | 1986 |
Gut microbiome alterations in Alzheimer’s disease | 2017 | 1947 |
Cerebrospinal fluid and plasma biomarkers in Alzhe... | 2010 | 1821 |
Neurofilaments as biomarkers in neurological disor... | 2018 | 1787 |
Association between CSF biomarkers and incipient A... | 2006 | 1669 |
Defeating Alzheimer's disease and other dementias:... | 2016 | 1619 |
Clearance systems in the brain—implications for Al... | 2015 | 1534 |
Discriminative Accuracy of Plasma Phospho-tau217 f... | 2020 | 1310 |
Hallmarks of neurodegenerative diseases | 2023 | 1286 |
Henrik Zetterberg is a researcher with 3702 publications and 171217 citations. They are affiliated with Roche Pharma AG (Germany). Their research focuses on . With an h-index of 186, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Henrik Zetterberg and 250M+ other papers.
Citations per publication by year